Ultimovacs ASA (ULTI) — Cash Flow-to-Debt Ratio
Latest as of December 2024:
-0.74x
Ultimovacs ASA (ULTI) has a Cash Flow-to-Debt Ratio of -0.74x as of December 2024, meaning its operating cash flow of Nkr-24.70 Million could theoretically repay -1% of its total liabilities (Nkr33.19 Million) in one year. See Ultimovacs ASA free cash flow to debt ratio to measure the company's free cash flow as a share of total liabilities.
CF-to-Debt Ratio
-0.74x
Operating CF / Total Liabilities
Operating Cash Flow
Nkr-24.70 Million
NOK
Total Liabilities
Nkr33.19 Million
NOK
Data as of
Dec 2024
Most recent filing
Ultimovacs ASA Cash Flow-to-Debt Ratio (2016–2024)
Historical debt coverage capacity for Ultimovacs ASA across 9 annual periods. For the full cash flow conversion analysis, see cash flow conversion of Ultimovacs ASA.
Annual Cash Flow-to-Debt Ratio for Ultimovacs ASA (2016–2024)
Year-by-year debt coverage analysis for Ultimovacs ASA.
| Year | CF-to-Debt Ratio | Operating CF (NOK) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2024 | -4.92x | Nkr-163.40 Million | Nkr33.19 Million | ▼ -80.6% |
| 2023 | -2.73x | Nkr-189.83 Million | Nkr69.65 Million | ▲ +2.0% |
| 2022 | -2.78x | Nkr-167.69 Million | Nkr60.32 Million | ▼ -37.8% |
| 2021 | -2.02x | Nkr-125.83 Million | Nkr62.38 Million | ▲ +23.0% |
| 2020 | -2.62x | Nkr-108.22 Million | Nkr41.34 Million | ▼ -38.9% |
| 2019 | -1.89x | Nkr-62.99 Million | Nkr33.41 Million | ▼ -12.1% |
| 2018 | -1.68x | Nkr-50.39 Million | Nkr29.96 Million | ▲ +23.7% |
| 2017 | -2.21x | Nkr-27.23 Million | Nkr12.35 Million | ▲ +51.7% |
| 2016 | -4.57x | Nkr-31.10 Million | Nkr6.81 Million | — |
Cash Flow-to-Debt Ratio = Operating Cash Flow / Total Liabilities. Higher is better for debt service capacity.